OBJECTIVES: To compare low contrast detail (LCD) detectability and radiation dose for routine paediatric chest X-ray (CXR) imaging protocols among various hospitals.METHODS: CDRAD 2.0 phantom and medical grade polymethyl methacrylate (PMMA) slabs were used to simulate the chest region of four different paediatric age groups. Radiographic acquisitions were undertaken on 17 X-ray machines located in eight hospitals using their existing CXR protocols. LCD detectability represented by image quality figure inverse (IQF inv) was measured physically using the CDRAD analyser software. Incident air kerma (IAK) measurements were obtained using a solid-state dosimeter. RESULTS: The range of IQF inv, between and within the hospitals, was 1.40-4.44 and 1.52-2.18, respectively for neonates; 0.96-4.73 and 2.33-4.73 for a 1-year old; 0.87-1.81 and 0.98-1.46 for a 5-year old and 0.90-2.39 and 1.27-2.39 for a 10-year old. The range of IAK, between and within the hospitals, was 8.56-52.62 μGy and 21.79-52.62 μGy, respectively for neonates; 5.44-82.82 μGy and 36.78-82.82 μGy for a 1-year old; 10.97-59.22 μGy and 11.75-52.94 μGy for a 5-year old and 13.97-100.77 μGy and 35.72-100.77 μGy for a 10-year old. CONCLUSIONS: Results show considerable variation, between and within hospitals, in the LCD detectability and IAK. Further radiation dose optimisation for the four paediatric age groups, especially in hospitals /X-ray rooms with low LCD detectability and high IAK, are required.
DOCUMENT
INTRODUCTION: With the introduction of digital radiography, the feedback between image quality and over-exposure has been partly lost which in some cases has led to a steady increase in dose. Over the years the introduction of exposure index (EI) has been used to resolve this phenomenon referred to as 'dose creep'. Even though EI is often vendor specific it is always a related of the radiation exposure to the detector. Due to the nature of this relationship EI can also be used as a patient dose indicator, however this is not widely investigated in literature.METHODS: A total of 420 dose-area-product (DAP) and EI measurements were taken whilst varying kVp, mAs and body habitus on two different anthropomorphic phantoms (pelvis and chest). Using linear regression, the correlation between EI and DAP were examined. Additionally, two separate region of interest (ROI) placements/per phantom where examined in order to research any effect on EI.RESULTS: When dividing the data into subsets, a strong correlation between EI and DAP was shown with all R-squared values > 0.987. Comparison between the ROI placements showed a significant difference between EIs for both placements.CONCLUSION: This research shows a clear relationship between EI and radiation dose which is dependent on a wide variety of factors such as ROI placement, body habitus. In addition, pathology and manufacturer specific EI's are likely to be of influence as well.IMPLICATIONS FOR PRACTICE: The combination of DAP and EI might be used as a patient dose indicator. However, the influencing factors as mentioned in the conclusion should be considered and examined before implementation.
DOCUMENT
Introduction: In clinical practice AP pelvis standard protocols are suitable for average size patients. However, as the average body size has increased over the past decades, radiographers have had to improve their practice in order to ensure that adequate image quality with minimal radiation dose to the patient is achieved. Gonad shielding has been found to be an effective way to reduce the radiation dose to the ovaries. However, the effect of increased body size, or fat thickness, in combination with gonad shielding is unclear. The goal of the study was to investigate the impact of gonad shielding in a phantom of adult female stature with increasing fat thicknesses on SNR (as a measure for image quality) and dose for AP pelvis examination. Methods: An adult Alderson female pelvis phantom was imaged with a variety of fat thickness categories as a representation of increasing BMI. 72 images were acquired using both AEC and manual exposure with and without gonad shielding. The radiation dose to the ovaries was measured using a MOSFET system. The relationship between fat thickness, SNR and dose when the AP pelvis was performed with and without shielding was investigated using the Wilcoxon signed rank test. P-values < 0.05 were considered to be statistically significant. Results: Ovary dose and SNR remained constant despite the use of gonad shielding while introducing fat layers. Conclusion: The ovary dose did not increase with an increase of fat thickness and the image quality was not altered. Implications for practice: Based on this phantom study it can be suggested that obese patients can expect the same image quality as average patients while respecting ALARA principle when using adequate protocols.
DOCUMENT
INTRODUCTION: In the Netherlands, Diagnostic Reference Levels (DRLs) have not been based on a national survey as proposed by ICRP. Instead, local exposure data, expert judgment and the international scientific literature were used as sources. This study investigated whether the current DRLs are reasonable for Dutch radiological practice.METHODS: A national project was set up, in which radiography students carried out dose measurements in hospitals supervised by medical physicists. The project ran from 2014 to 2017 and dose values were analysed for a trend over time. In the absence of such a trend, the joint yearly data sets were considered a single data set and were analysed together. In this way the national project mimicked a national survey.RESULTS: For six out of eleven radiological procedures enough data was collected for further analysis. In the first step of the analysis no trend was found over time for any of these procedures. In the second step the joint analysis lead to suggestions for five new DRL values that are far below the current ones. The new DRLs are based on the 75 percentile values of the distributions of all dose data per procedure.CONCLUSION: The results show that the current DRLs are too high for five of the six procedures that have been analysed. For the other five procedures more data needs to be collected. Moreover, the mean weights of the patients are higher than expected. This introduces bias when these are not recorded and the mean weight is assumed to be 77 kg.IMPLICATIONS FOR PRACTICE: The current checking of doses for compliance with the DRLs needs to be changed. Both the procedure (regarding weights) and the values of the DRLs should be updated.
DOCUMENT
PURPOSE: Advanced radiotherapy treatments require appropriate quality assurance (QA) to verify 3D dose distributions. Moreover, increase in patient numbers demand efficient QA-methods. In this study, a time efficient method that combines model-based QA and measurement-based QA was developed; i.e., the hybrid-QA. The purpose of this study was to determine the reliability of the model-based QA and to evaluate time efficiency of the hybrid-QA method.METHODS: Accuracy of the model-based QA was determined by comparison of COMPASS calculated dose with Monte Carlo calculations for heterogeneous media. In total, 330 intensity modulated radiation therapy (IMRT) treatment plans were evaluated based on the mean gamma index (GI) with criteria of 3%∕3mm and classification of PASS (GI ≤ 0.4), EVAL (0.4 < GI > 0.6), and FAIL (GI ≥ 0.6). Agreement between model-based QA and measurement-based QA was determined for 48 treatment plans, and linac stability was verified for 15 months. Finally, time efficiency improvement of the hybrid-QA was quantified for four representative treatment plans.RESULTS: COMPASS calculated dose was in agreement with Monte Carlo dose, with a maximum error of 3.2% in heterogeneous media with high density (2.4 g∕cm(3)). Hybrid-QA results for IMRT treatment plans showed an excellent PASS rate of 98% for all cases. Model-based QA was in agreement with measurement-based QA, as shown by a minimal difference in GI of 0.03 ± 0.08. Linac stability was high with an average GI of 0.28 ± 0.04. The hybrid-QA method resulted in a time efficiency improvement of 15 min per treatment plan QA compared to measurement-based QA.CONCLUSIONS: The hybrid-QA method is adequate for efficient and accurate 3D dose verification. It combines time efficiency of model-based QA with reliability of measurement-based QA and is suitable for implementation within any radiotherapy department.
DOCUMENT
Een fles rode wijn per dag drinken is ongezond, maar een glas per dag reduceert mogelijk de kans op hartkwalen. Dit is een voorbeeld van ‘hormese’: het verschijnsel dat een agens dat in grote hoeveelheden schadelijk is, bij lage doses juist gezond is. Iets vergelijkbaars geldt voor zonlicht: lage doses worden geassocieerd met positieve gezondseffecten, hoge doses met verbranden en een hogere kans op huidkanker. Er zijn onderzoekers die zich op het omstreden standpunt stellen dat ook ioniserende straling hormetische eigenschappen heeft. In dit artikel gaan we nader in op de verschillende standpunten omtrent lage-dosiseffecten, de argumenten voor en tegen hormese en de consequenties van recente inzichten.
DOCUMENT
Onze leef- en werkomgeving heeft invloed op onze gezondheid, maar het nauwkeurig bepalen van persoonlijke blootstelling aan verschillende milieufactoren blijft een uitdaging. Toch is dit wel van belang, omdat bijvoorbeeld de blootstelling aan fijnstof, stikstofdioxide en ozon jaarlijks al leidt tot 12.000 vroegtijdige sterfgevallen in Nederland (Gezondheidsraad, 2018). In werkomgevingen zijn er behalve voor de genoemde stoffen ook nog andere vluchtig organische stoffen en chemicalen waarvan de blootstelling op de korte of lange termijn tot negatieve gezondheidseffecten kan leiden. Ook fysische blootstellingen kunnen negatieve gezondheidseffecten hebben, zoals geluid, UV-straling, elektromagnetische velden en trillingen.
DOCUMENT
Voor patiënten die radiologische verrichtingen ondergaan bestaan geen dosislimieten, maar wel zogenaamde Diagnostische ReferentieNiveaus (DRN’s). Dit zijn richtwaarden voor de hoeveelheid straling voor de gemiddelde patiënt bij goede praktijkvoering. In Nederland bestaan nationale DRN’s voor slechts 11 radiologische verrichtingen. In andere Europese landen zijn dat er vaak beduidend meer. Zo ontbreken in Nederland DRN’s voor interventie-radiologische verrichtingen (interventies), terwijl dit juist verrichtingen zijn waarbij vaak relatief hoge stralingsdoses worden uitgedeeld. In deze studie, die gebaseerd is op het afstudeerwerk van twee van de auteurs (GH en MtS), is als proof-of-principle een lokaal DRN afgeleid uit data van een enkel ziekenhuis (het Dijklander ziekenhuis). Voor dit lokale DRN is data verzameld van percutane transluminale angioplastiek (PTA) in de arteria femoralis superficialis (AFS), uitgevoerd met dezelfde apparatuur in één angiografiekamer door twee radiologen. In totaal zijn daarbij 52 complicatievrije interventies geïncludeerd. Uit de verzamelde data is als 75 percentielwaarde een lokaal DRN voor PTA van de AFS afgeleid van 50,9 Gy*cm2. Dit is ruim 20 Gy*cm2 lager dan gevonden in twee andere Europese studies. In die studies werd daarentegen wel veel meer data geïncludeerd van verschillende radiologie-afdelingen. Deze studie laat zien dat het ook in Nederland mogelijk is om voor een interventie een DRN op te stellen. Het verdient de aanbeveling deze studie te herhalen of uit te breiden met data van diverse andere Nederlandse ziekenhuizen om zodoende een nationaal DRN te bepalenn
DOCUMENT
Recent onderzoek onder jongeren heeft aangetoond dat slapeloosheid en groot probleem is.In het artikel wordt duidelijk gemaakt dat de mobiele telefoon, computers en elektromagenetische straling daarin een grote rol spelen maar niet genoemd worden.
DOCUMENT
Bij het 11e lustrum van de NVS is uitgebreid stilgestaan bij de zogenaamde stralingstaart, die weergeeft aan welke bronnen van ioniserende straling Nederlanders worden blootgesteld [Sla15]. De grootste taartpunt in die stralingstaart komt voor rekening van de medische diagnostiek. Het gaat daarbij met name om medische beeldvorming met röntgenstraling (röntgenfoto’s en CT scans) en in mindere mate om diagnostiek met radiofarmaca (nucleaire geneeskunde). Stralingsbelasting ten gevolge van radiotherapie en nucleair geneeskundige therapie wordt hier buiten beschouwing gelaten. Daarbij is straling voornamelijk het ‘medicijn’ en spelen mogelijke negatieve bijwerkingen een ondergeschikte rol. De stralingsbelasting ten gevolge van medische diagnostiek wordt bijgehouden in het Informatiesysteem Medische Stralingsbelasting (www.rivm.nl/ims). Daaruit blijkt dat die stralingsbelasting van jaar tot jaar toeneemt (zie Figuur 1). Dit wordt veroorzaakt door de toename in het aantal verrichtingen dat jaarlijks wordt uitgevoerd.
DOCUMENT
